text:
EX-99.2
3
exhibit99-2form8k2014octno.htm
EXHIBIT 99-2 PRESS RELEASE
Exhibit99-2form8k2014octNorway
Exhibit 99.2
Marathon Oil Closes Transaction for Sale of Norway Business
HOUSTON, Oct. 15, 2014 - Marathon Oil Corporation (NYSE: MRO) announced today it has closed the transaction with Det norske oljeselskap ASA for the sale of Marathon Oil Norge AS for a total transaction value of $2.7 billion. After adjustment for debt, net working capital and interest on the net purchase price, Marathon Oil received proceeds of approximately $2.1 billion. The effective date of the transaction is Jan. 1, 2014.
"The sale of the Norway business was one of Marathon Oil's strategic priorities for 2014 and a continuation of our portfolio optimization strategy", said Lee M. Tillman, Marathon Oil's president and CEO. "The successful closing of this transaction simplifies and concentrates our portfolio, and further demonstrates our commitment to rigorous portfolio management. Importantly, organic reinvestment is our first priority for the proceeds, and we have the depth of resource and future drilling inventory to support it.
"This ability to execute on our strategy and deliver industry-leading results is the foundation for Marathon Oil becoming the premier independent exploration and production company", he emphasized.
The Norway sale includes the operated Alvheim floating production, storage and offloading (FPSO) vessel, 10 Company-operated licenses and a number of non-operated licenses on the Norwegian Continental Shelf in the North Sea. Full-year 2013 net production in Norway averaged approximately 80,000 barrels of oil equivalent (BOE) per day.
Marathon Oil Corporation is a global exploration and production company. Based in Houston, Texas, the Company had net proved reserves at the end of 2013 of 2.2 billion barrels of oil equivalent in North America, Europe and Africa. For more information, please visit our website at http://www.marathonoil.com.
# # #
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are statements other than statements of historical fact that give current expectations or forecasts of future events, including but not limited to Marathon Oil's operational, financial and growth strategies, ability to successfully effect those strategies and the expected results therefrom, the expected use of proceeds from the sale, statements related to Marathon Oil's resources and future drilling inventory, and Marathon Oil's intention to become the premier independent exploration and production company. While Marathon Oil believes that the assumptions concerning future events are reasonable, a number of factors could cause results to differ materially from those indicated by such forward-looking statements including, but not limited to:conditions in the oil and gas industry, including pricing, supply and demand for liquid hydrocarbons and natural gas, changes in political or economic conditions in key operating markets, including international markets, the amount of capital available for exploration and development, timing of commencing production from new wells, drilling rig availability, availability of materials and labor, the inability to obtain or delay in obtaining necessary government or third-party approvals and permits, non-performance by third parties of their contractual obligations, unforeseen hazards such as weather conditions, acts of war or terrorist acts and the governmental or military response thereto, changes in safety, health, environmental and other regulations, and other geological, operating and economic considerations. These forward-looking
statements are also affected by the risk factors, forward-looking statements and challenges and uncertainties described in Marathon Oil's Annual Report on Form 10-K for the year ended December 31, 2013, and those set forth from time to time in Marathon Oil's filings with the Securities and Exchange Commission, which are currently available at www.marathonoil.com. Except as required by law, Marathon Oil expressly disclaims any intention or obligation to revise or update any forward-looking statements whether as a result of new information, future events or otherwise.
Media Relations Contacts
Lee Warren: 713-296-4103
Lisa Singhania: 713-296-4101
Investor Relations Contact
Chris Phillips: 713-296-3213

text: Marathon Oil

text: Marathon Oil Corporation

text: Det norske oljeselskap ASA

text: Marathon Oil Norge AS

text: Marathon Oil

text: Marathon Oil

text: Marathon Oil

text: Marathon Oil

text: Marathon Oil Corporation

text: Marathon Oil

text: Marathon Oil

text: Marathon Oil

text: Marathon Oil

text: Marathon Oil

text: Marathon Oil

text: Marathon Oil


dataset: buster

text:
EX-99.1
3
a2011q308-kex991prdotomiacq.htm
EXHIBIT 99.1
2011 Q3 08-K Ex 99.1 PR Dotomi Acq.
Exhibit 99.1
For Immediate Release
Contact:
Gary J. Fuges, CFA
ValueClick, Inc.
1.818.575.4677
VALUECLICK COMPLETES ACQUISITION OF DOTOMI
Company Repurchased 3.4 Million Shares since August 5
Board Increases Share Repurchase Program's Total Authorization to $100 Million
Westlake Village, CA - August 31, 2011 - ValueClick (Nasdaq: VCLK) announced today that it has closed its acquisition of Dotomi, the leading provider of data-driven, intelligent display media for major retailers. The Company also announced an update on its share repurchase program, including the repurchase of 3.4 million shares since August 5 and an increase in its total repurchase authorization to $100 million.
"We are thrilled to formally welcome Dotomi to ValueClick, as their expertise and scale complement our strengths in performance-based display and affiliate marketing", said James Zarley, chief executive officer of ValueClick. "As illustrated by our recent share repurchase activity and our board's increased share repurchase authorization, we remain confident in our ability to gain market share as our Media division expands further into branding, mobile and video and capitalizes on cross-selling opportunities with our affiliate marketing advertisers. We are committed to offsetting the shares issued in the Dotomi transaction with continued share repurchase activity".
Dotomi Acquisition Closed
ValueClick has acquired all of the outstanding equity interests in Dotomi for upfront consideration consisting of: (a) 7.1 million shares of ValueClick common stock; (b) the assumption of 0.5 million fully vested stock options; and (c) $148 million in cash (net of cash acquired). In addition, ValueClick has assumed 0.4 million shares of unvested restricted stock which will vest over a one year period and 0.5 million unvested stock options which will vest over a period ranging from one to three years.
A portion of the acquisition was funded by the Company's Amended and Restated Credit Agreement, as described in the Company's Form 8-K filed with the Securities and Exchange Commission on August 24. This credit agreement provides the Company with $200 million of total available credit with a five year term, including a senior secured revolving credit facility of $150 million and a $50 million term loan.
John Giuliani will continue to lead Dotomi and will report directly to ValueClick chief executive officer, James Zarley. Additionally, Mr. Giuliani has joined ValueClick's board of directors.
Dotomi's results of operations will be included in ValueClick's consolidated and Media segment results beginning on August 31, 2011. For the one month period ended September 30, 2011, ValueClick anticipates that Dotomi will contribute approximately $8.5 million in revenue. The acquisition is expected to add approximately $2 million in amortization expense and approximately $1 million in stock-based compensation expense to ValueClick's third quarter results. Dotomi was not included in the Company's third quarter 2011 guidance provided on August 2.
Share Repurchase Program Update
Today, ValueClick also provided an update on its share repurchase program. Since August 5, the Company has repurchased 3.4 million shares of its common stock for a total cost of $49.5 million. These repurchases represent over
44 percent of the shares issued upon closing of the Dotomi acquisition. Year to date, ValueClick has repurchased 6.0 million shares of its common stock for a total cost of $87.2 million.
Additionally, the Company announced that its board of directors has increased the share repurchase program authorization by $86 million, bringing the current share repurchase program authorization to $100 million. The Company intends to continue to use its share repurchase program to offset the shares issued in the Dotomi acquisition.
About ValueClick
ValueClick, Inc. (Nasdaq: VCLK) is one of the world's largest digital marketing companies. Through a unique combination of data, technology and services, ValueClick increases brand awareness and drives customer acquisition at scale for the world's largest advertisers, and maximizes advertising revenue for tens of thousands of online and mobile publishers. ValueClick's brands include Commission Junction, ValueClick Media, Dotomi, Greystripe, Mediaplex, Smarter.com, CouponMountain.com, Investopedia.com, and PriceRunner. The Company is based in Westlake Village, California, and has offices in major advertising markets worldwide. For more information, please visit www.valueclick.com.
This release contains forward-looking statements that involve risks and uncertainties, including, but not limited to, the risk that market demand for on-line advertising in general, and performance based on-line advertising in particular, will not grow as rapidly as predicted, the risk that legislation and governmental regulation could negatively impact the Company's performance, the effects of the Dotomi acquisition on ValueClick's financial results, and the potential inability to successfully operate or integrate Dotomi's business, including the potential inability to retain customers, key employees or vendors. Actual results may differ materially from the results predicted, and reported results should not be considered an indication of future performance. Important factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements are detailed under "Risk Factors" and elsewhere in filings with the Securities and Exchange Commission made from time to time by ValueClick, including, but not limited to: its annual report on Form 10-K filed on February 28, 2011; recent quarterly reports on Form 10-Q; and other current reports on Form 8-K.
The Business Outlook contained in this release is based on current expectations. These statements are forward-looking, and actual results may differ materially. These statements do not include the potential impact of any mergers, acquisitions or other business combinations that may be completed after the date of this release. Actual stock-based compensation may differ from these estimates based on the timing and amount of stock awards granted, the assumptions used in stock award valuation and other factors. Actual income tax expense may differ from these estimates based on tax planning, changes in tax accounting rules and laws, and other factors.
ValueClick undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
###

label: organization

text: Dotomi

text: ValueClick

text: VALUECLICK

text:
DOTOMI
Company

text: ValueClick

text: Dotomi

text: Dotomi

text: ValueClick

label: person

text: James Zarley

text: ValueClick

text: Dotomi

text: Dotomi

text: ValueClick

text: Dotomi

text: ValueClick

text: ValueClick

text: Dotomi

text: ValueClick

text: James Zarley

text: ValueClick

text: Dotomi

text: ValueClick

text: ValueClick

text: Dotomi

text: ValueClick

text: Dotomi

text: ValueClick

text: Dotomi

text: ValueClick

text: Dotomi

text: ValueClick

text: ValueClick

text: ValueClick

text: ValueClick

text: ValueClick

text: Dotomi

text: Dotomi

text: ValueClick

text: Dotomi

text: ValueClick

text: ValueClick

source_dataset: expertai/BUSTER

annotation_scope: BUSTER company-role spans plus reviewed organization, fund, person, and event additions with document-local surface projection; annotations remain non-exhaustive


text:
EX-99.1
3
trcr8k20110801salarex991.htm
EXHIBIT 99.1
TRCR 8K 2011 0801 Salar Ex99.1
Exhibit 99.1
FOR IMMEDIATE RELEASE
Contacts:
Neil Berkman, Investor Relations, 310-826-5051, nberkman@berkmanassociates.com
Larry Gerdes, CEO, 678-808-0600, larry.gerdes@trcr.com
Lance Cornell, CFO, 678-808-0600, lance.cornell@trcr.com
Transcend Announces Acquisition of Salar
Salar's electronic clinical documentation and billing workflow solutions will further Transcend's diversification into the hospital setting
Aug. 1, 2011
(BW) (TRANSCEND SERVICES, INC.) (TRCR)
ATLANTA - Clinical documentation solutions company TRANSCEND SERVICES INC. (NASDAQ: TRCR) today announced its acquisition of Salar Inc. (pronounced Sâlar), a privately held provider of electronic clinical documentation and billing workflow solutions for healthcare providers, in an $11 million cash for stock transaction that closed July 29, 2011. It is anticipated that the acquisition will give Transcend a stronger foothold in the hospital setting and provide its customers added functionality and flexibility.
Founded in 1999 and headquartered in Baltimore, Salar's solutions are used by leading academic and community hospitals. The company generated $4 million of revenue and $1.2 million of operating income in 2010 and is growing.
"This acquisition is key to both our growth and diversification strategies", said Larry Gerdes, Transcend chairman and CEO. "From a growth perspective, the purchase is in line with our strategy of complementing our organic growth by completing selected strategic acquisitions, of which Salar is the sixth since the beginning of 2009. Salar, however, allows us to diversify because it's the first of these companies to offer software products. Our purchase of Salar's flexible and physician-centric products combined with the recent availability of our Encore medical transcription platform offered to hospitals under the Software as a Service (SaaS) model, will allow us further entry into the hospital setting".
"As a leading provider of transcription services, we have been asked by many of our customer partners for assistance with the adoption of meaningful use of clinical data", stated Susan McGrogan, president & COO of Transcend. "Partnering with our customers has always been vital to providing the highest level of service, and by incorporating Salar's innovative technology; we will be better positioned to respond to our customers' needs".
Salar product solutions - which include Team Notes,™ TeamRelay,™ TeamQuery™ and TAP Charge Capture™ - provide a highly customizable and physician-friendly interface that integrates easily with existing electronic medical record systems, allowing physicians and hospitals to achieve notable productivity, financial and patient safety improvements. Hospitals can enhance their investment in existing Healthcare Information Systems (HIS) by overlaying Salar's products to achieve high levels of physician adoption and return on investment utilizing a Meaningful Use Stage 1 certified product.
"With Salar's complementary technology, we will be able to move our own speech recognition technology into templates, allowing us to expand our customer base to include clinicians who prefer template-based clinical documentation solutions, and enabling our solutions to meet "meaningful use" of EMRs", said Ken Ravenelle, Transcend chief technology officer. "In 2012, we anticipate the ability to combine our respective technologies into a hybrid that will give our Encore customers added functionality and greater flexibility".
Added Todd Johnson, Salar president and co-founder, "By incorporating Transcend's dictation, speech recognition and document delivery technologies into Salar's tools, we will further help customers achieve broad physician adoption and maximize physician productivity. Healthcare systems and hospitals can now support the way their physicians' work, while incorporating the most cost-effective solution. The technology that Salar and Transcend bring encompass clinical workflow processes electronically, which are very manual today. This enables us to better leverage the overall adoption of a true electronic record and limit the need for scanning records into the EMR. In fact, Salar's TAP Charge Capture application completes billing charges at the point-of-care. TAP eliminates traditional, labor-intensive and error prone billing processes by allowing physicians to complete charge entry online or automating billing from the physician's documentation. "
Johnson went on to say that both Salar and Transcend are dedicated to providing an outstanding, responsive service experience for every customer. "I couldn't ask for a more closely aligned partner than Transcend to fuel Salar's growth and deliver increased value to Transcend's customers".
Salar will remain in its Baltimore location and operate as a business unit of Transcend.
About Transcend Services, Inc.
Transcend Services is a leading provider of clinical documentation solutions for healthcare organizations. The company's high-quality transcription services and applications - along with leading data extraction and reporting tools - provide critical data needed to document patient encounters and help drive clinical decision making. Transcend provides clients with exceptional quality, turnaround time and service so that they can focus on what matters most - their patients. For more information, visit www.transcendservices.com.
About Salar
Salar delivers the healthcare industry's most flexible and physician-centric inpatient documentation and billing solutions. Each Salar product provides a highly customizable physician interface that integrates easily with existing electronic medical record systems. With Salar, physicians and hospitals alike achieve notable productivity, financial and patient safety improvements. Founded in 1999 and headquartered in Baltimore, Salar's solutions are used by many of the nation's prominent hospitals. For more information, please call 1-888-577-2527 or visit www.salarinc.com.
Safe Harbor Statement
This press release contains certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that represent our expectations, anticipations or beliefs about future events, including our operating results, financial condition, liquidity, expenditures, and compliance with legal and regulatory requirements. For this purpose, any statements that are not statements of historical fact may be deemed to be forward-looking statements. These statements involve risks and uncertainties that could cause actual results to differ materially depending on a variety of important factors. Factors that might cause or contribute to such differences include, but are not limited to, competitive pressures, extraordinary expenses, loss of significant customers, the mix of revenue, changes in pricing policies, delays in revenue recognition, challenges encountered in integrating acquired businesses, increased regulatory burdens, lower-than-expected demand for the Company's products and services, failure to expand customer relationships or realize revenues from sales closed in the current quarter, the Company's position for growth, delays in the development of the Company's transcription platform, business conditions in the integrated health care delivery network market, adverse general economic conditions, and the risk factors detailed in our periodic, quarterly and annual reports on Forms 8-K, 10-Q and 10-K that we file with the Securities Exchange Commission ("SEC") from time to time. With respect to such forward-looking statements, we claim protection under the Private Securities Litigation Reform Act of 1995. Our SEC filings are available from us, and also may be examined at public reference facilities maintained by the SEC or, to the extent filed via EDGAR, accessed through the website of the SEC (http://www.sec.gov). In addition, factors that we are not currently aware of could harm our future operating results. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release. We undertake no obligation to make any revisions to the forward-looking statements or to reflect events or circumstances after the date of this press release.

text: Salar

text: Larry Gerdes

text: Lance Cornell

text: Transcend

text: Salar

text: Salar

text: Transcend

text: TRANSCEND SERVICES INC.

text: Salar Inc.

text: Transcend

text: Salar

text: Larry Gerdes

text: Transcend

text: Salar

text: Salar

text: Salar

text: Transcend

text: Salar

text: Salar

text: Salar

text: Salar

text: Transcend

text: Salar

text: Transcend

text: Salar

text: Salar

text: Transcend

text: Salar

text: Salar

text: Transcend

text: Transcend

text: Salar

text: Transcend

text: Salar

text: Transcend

text: Transcend

text: Salar

text: Salar

text: Salar

text: Salar

text: Salar